These effects, together with a earlier report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two help the notion of focusing on ACKR3 as a singular strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-rela